Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


24.07.2017

2 Am J Surg
2 Ann Surg Oncol
2 BMC Cancer
1 Br J Cancer
2 Breast Cancer Res
6 Breast Cancer Res Treat
1 Breast J
2 Cancer Chemother Pharmacol
2 Cancer Res
1 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
1 Int J Cancer
2 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
2 Nat Rev Clin Oncol
1 Nature
4 Oncol Rep
2 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. FAYANJU OM, Hall CS, Bauldry JB, Karhade M, et al
    Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer.
    Am J Surg. 2017 Jun 23. pii: S0002-9610(17)30118.
    PubMed     Text format     Abstract available

  2. CANDELARIA RP, Hansakul P, Thompson AM, Le-Petross H, et al
    Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?
    Am J Surg. 2017 Jul 1. pii: S0002-9610(17)30237.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. MITTENDORF EA, Chavez-MacGregor M, Vila J, Yi M, et al
    Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
    Ann Surg Oncol. 2017 Jul 19. doi: 10.1245/s10434-017-6009.
    PubMed     Text format     Abstract available

  4. MAMTANI A, Patil S, Stempel M, Morrow M, et al
    Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Ann Surg Oncol. 2017 Jul 17. doi: 10.1245/s10434-017-6004.
    PubMed     Text format    


    BMC Cancer

  5. WANG Q, Cheng Y, Wang Y, Fan Y, et al
    Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    BMC Cancer. 2017;17:492.
    PubMed     Text format     Abstract available

  6. YANES T, Meiser B, Young MA, Kaur R, et al
    Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.
    BMC Cancer. 2017;17:491.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. SMITH A, Murphy L, Zgaga L, Barron TI, et al
    Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer.
    Br J Cancer. 2017 Jul 18. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  8. FORTNER RT, Tolockiene E, Schock H, Oda H, et al
    Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case-control study in the Northern Sweden Maternity Cohort.
    Breast Cancer Res. 2017;19:82.
    PubMed     Text format     Abstract available

  9. REINER AS, Lynch CF, Sisti JS, John EM, et al
    Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
    Breast Cancer Res. 2017;19:83.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  10. MILLER P, Kidwell KM, Thomas D, Sabel M, et al
    Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
    Breast Cancer Res Treat. 2017 Jul 17. doi: 10.1007/s10549-017-4366.
    PubMed     Text format     Abstract available

  11. GUO L, Yuan P, Zhang J, Ling Y, et al
    Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer.
    Breast Cancer Res Treat. 2017 Jul 15. doi: 10.1007/s10549-017-4397.
    PubMed     Text format     Abstract available

  12. CHANG JS, Ko BK, Bae JW, Yu JH, et al
    Radiation-related heart disease after breast cancer radiation therapy in Korean women.
    Breast Cancer Res Treat. 2017 Jul 17. doi: 10.1007/s10549-017-4398.
    PubMed     Text format     Abstract available

  13. IGLAY K, Santorelli ML, Hirshfield KM, Williams JM, et al
    Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness.
    Breast Cancer Res Treat. 2017 Jul 19. doi: 10.1007/s10549-017-4399.
    PubMed     Text format     Abstract available

  14. GONZALEZ-RIVERA M, Lobo M, Lopez-Tarruella S, Jerez Y, et al
    Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
    Breast Cancer Res Treat. 2017 Jul 18. doi: 10.1007/s10549-017-4396.
    PubMed     Text format    

  15. SCHOORMANS D, van de Poll-Franse L, Vissers P, van Herk-Sukel MPP, et al
    Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors.
    Breast Cancer Res Treat. 2017 Jul 17. doi: 10.1007/s10549-017-4387.
    PubMed     Text format     Abstract available


    Breast J

  16. LEHRER S, Green S, Rosenzweig KE
    Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer.
    Breast J. 2017 Jul 20. doi: 10.1111/tbj.12880.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  17. PEER CJ, Lee JM, Roth J, Rodgers L, et al
    Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women's cancers.
    Cancer Chemother Pharmacol. 2017;80:165-175.
    PubMed     Text format     Abstract available

  18. SMIYUN G, Azarenko O, Miller H, Rifkind A, et al
    betaIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
    Cancer Chemother Pharmacol. 2017;80:151-164.
    PubMed     Text format     Abstract available


    Cancer Res

  19. RANGEL R, Guzman-Rojas L, Kodama T, Kodama M, et al
    Identification of new tumor suppressor genes in triple-negative breast cancer.
    Cancer Res. 2017 Jul 19. pii: canres.0785.2017.
    PubMed     Text format     Abstract available

  20. SALVADOR F, Martin A, Lopez-Menendez C, Moreno-Bueno G, et al
    Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer.
    Cancer Res. 2017 Jul 18. pii: canres.3152.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  21. CHEN T, Zhang N, Moran MS, Su P, et al
    Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2017 Jun 23. pii: S1526-8209(16)30550.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  22. SUN J, Meng H, Yao L, Lv M, et al
    Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
    Clin Cancer Res. 2017 Jul 19. pii: clincanres.3227.2016.
    PubMed     Text format     Abstract available


    Eur J Cancer

  23. DIMITROVA N, Znaor A, Agius D, Eser S, et al
    Breast cancer in South-Eastern European countries since 2000: Rising incidence and decreasing mortality at young and middle ages.
    Eur J Cancer. 2017;83:43-55.
    PubMed     Text format     Abstract available


    Int J Cancer

  24. NILENDU P, Kumar A, Kumar A, Pal JK, et al
    Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30898.
    PubMed     Text format     Abstract available


    Int J Oncol

  25. NGUYEN CH, Huttary N, Atanasov AG, Chatuphonprasert W, et al
    Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
    Int J Oncol. 2017;50:1879-1888.
    PubMed     Text format     Abstract available

  26. ILKOVICOVA L, Trost N, Szentpeteriova E, Solar P, et al
    Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen.
    Int J Oncol. 2017;51:737-746.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  27. SPIEGEL D
    Breast Cancer: Biology or Stage?
    Int J Radiat Oncol Biol Phys. 2017;98:974-975.
    PubMed     Text format    


    J Clin Oncol

  28. REEDER-HAYES KE, Meyer AM, Hinton SP, Meng K, et al
    Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.
    J Clin Oncol. 2017 Jul 20:JCO2016714345. doi: 10.1200/JCO.2016.71.4345.
    PubMed     Text format     Abstract available


    Nat Rev Clin Oncol

  29. KILLOCK D
    Breast cancer: Profiling of ultra-low-risk disease.
    Nat Rev Clin Oncol. 2017 Jul 18. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    

  30. HUTCHINSON L
    Prevention: Low-fat diet linked to decline in breast cancer mortality.
    Nat Rev Clin Oncol. 2017 Jul 18. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


    Nature

  31. ZHAO D, Lu X, Wang G, Lan Z, et al
    Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
    Nature. 2017;542:484-488.
    PubMed     Text format     Abstract available


    Oncol Rep

  32. GUTIERREZ DIEZ PJ, Su Y, Russo J
    Immunocytochemical stem cell markers can predict clinical stage of breast cancer.
    Oncol Rep. 2017 Jul 14. doi: 10.3892/or.2017.5820.
    PubMed     Text format     Abstract available

  33. BARRON GA, Goua M, Wahle KWJ, Bermano G, et al
    Circulating levels of angiogenesis-related growth factors in breast cancer: A study to profile proteins responsible for tubule formation.
    Oncol Rep. 2017 Jul 11. doi: 10.3892/or.2017.5803.
    PubMed     Text format     Abstract available

  34. YANG XL, Liu KY, Lin FJ, Shi HM, et al
    CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
    Oncol Rep. 2017 Jul 7. doi: 10.3892/or.2017.5798.
    PubMed     Text format     Abstract available

  35. SHIBATA M, Kanda M, Tanaka H, Umeda S, et al
    Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells.
    Oncol Rep. 2017 Jul 10. doi: 10.3892/or.2017.5800.
    PubMed     Text format     Abstract available


    PLoS One

  36. PASCUAL T, Apellaniz-Ruiz M, Pernaut C, Cueto-Felgueroso C, et al
    Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer.
    PLoS One. 2017;12:e0180192.
    PubMed     Text format     Abstract available

  37. KONG W, Mou X, Deng J, Di B, et al
    Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
    PLoS One. 2017;12:e0180337.
    PubMed     Text format     Abstract available


    Radiology

  38. ALTUNDAG K
    Association between Computer-aided Diagnosis-measured Peak Enhancement and Washout Component at Preoperative MR Imaging and Operable Hormone Receptor-positive Breast Cancer.
    Radiology. 2017;284:604.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: